Schedule 13G ownership disclosure

ENZO BIOCHEM INC

Common Stock · CUSIP: 294100102

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Beryl Capital Management LLC

    Shares: 0.00 · Class: 0%

  • Beryl Capital Management LP

    Shares: 0.00 · Class: 0%

  • Beryl Capital Partners II LP

    Shares: 0.00 · Class: 0%

  • David A. Witkin

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000691
Form type
SCHEDULE 13G/A
Filer
Beryl Capital Management LLC
CIK
CIK 1719307
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub